Volume 8, Issue 1, January 2019, Page: 10-22
Lactulose Crystals Beneficially Affect Community Composition Along Entire Human Colon in Vitro, Resulting in Donor-Dependent Prebiotic Effects at Metabolic Level
Cindy Duysburgh, Pro Digest Bvba, Ghent, Belgium
Pieter Van Den Abbeele, Pro Digest Bvba, Ghent, Belgium
Melanie Bothe, Fresenius-Kabi Deutschland GmbH, Bad Homburg, Germany
John Stover, Fresenius-Kabi Deutschland GmbH, Oberursel, Germany
Angelika Kuchinka-Koch, Fresenius-Kabi Austria GmbH, Linz, Austria
Susann Schwejda-Guettes, Fresenius-Kabi Deutschland GmbH, Oberursel, Germany
Massimo Marzorati, Pro Digest Bvba, Ghent, Belgium; Center of Microbial Ecology and Technology (CMET), Ghent University, Ghent, Belgium
Received: Feb. 12, 2019;       Accepted: Mar. 20, 2019;       Published: Apr. 29, 2019
DOI: 10.11648/j.ijnfs.20190801.12      View  250      Downloads  75
Abstract
A validated in vitro gut model (i.e. SHIME®) was used to assess the effect of repeated daily administration of lactulose on microbial metabolic activity and community composition in different colonic areas, with the focus on inter-individual differences among three human subjects. An initial rise in acetate and lactate levels was observed in the proximal colon after lactulose administration, which could be linked to an overall strong bifidogenic effect as well as higher Lactobacilli levels in donors 2 and 3. Particularly two operational taxonomic units (OTUs) related to Bifidobacterium adolescentis and Bifidobacterium longum increased with lactulose addition. The enhanced acetate and lactate production subsequently stimulated microbial species involved in cross-feeding interactions, resulting in the donor-dependent production of propionate and/or butyrate. Additionally, a reduction in markers of proteolytic fermentation was detected upon lactulose supplementation. A wide spectrum of propionate- and especially butyrate-producing microbes, such as the next-generation probiotics Faecalibacterium prausnitzii and Akkermansia muciniphila, were donor-dependently enhanced in the distal colon, which is of specific interest as many colonic diseases originate in the distal part of the colon. For the first time beneficial effects of lactulose on the microbiota as well as metabolic activity could be demonstrated over the entire colon in vitro.
Keywords
Bifidobacteria, Faecalibacterium, Akkermansia, SHIME®, Microbial
To cite this article
Cindy Duysburgh, Pieter Van Den Abbeele, Melanie Bothe, John Stover, Angelika Kuchinka-Koch, Susann Schwejda-Guettes, Massimo Marzorati, Lactulose Crystals Beneficially Affect Community Composition Along Entire Human Colon in Vitro, Resulting in Donor-Dependent Prebiotic Effects at Metabolic Level, International Journal of Nutrition and Food Sciences. Vol. 8, No. 1, 2019, pp. 10-22. doi: 10.11648/j.ijnfs.20190801.12
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Gibson, G. R., et al., Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol, 2017. 14 (8): p. 491-502.
[2]
Panesar, P. S. and S. Kumari, Lactulose: production, purification and potential applications. Biotechnol Adv, 2011. 29 (6): p. 940-8.
[3]
Mao, B., et al., In vitro fermentation of lactulose by human gut bacteria. J Agric Food Chem, 2014. 62 (45): p. 10970-7.
[4]
Bass, P. and S. Dennis, The laxative effects of lactulose in normal and constipated subjects. J Clin Gastroenterol, 1981. 3 Suppl 1: p. 23-8.
[5]
Weber, F. L., Jr., Lactulose and combination therapy of hepatic encephalopathy: the role of the intestinal microflora. Dig Dis, 1996. 14 Suppl 1: p. 53-63.
[6]
Brommage, R., et al., Intestinal calcium absorption in rats is stimulated by dietary lactulose and other resistant sugars. J Nutr, 1993. 123 (12): p. 2186-94.
[7]
Van den Heuvel, E. G., et al., Lactulose stimulates calcium absorption in postmenopausal women. J Bone Miner Res, 1999. 14 (7): p. 1211-6.
[8]
Bouhnik, Y., et al., Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans. Eur J Clin Nutr, 2004. 58 (3): p. 462-6.
[9]
Mizota, T., et al., Effects of low dosages of lactulose on the intestinal function of healthy adults. Vol. 57. 2002. 312-315.
[10]
Terada, A., et al., Effect of Lactulose on the Composition and Metabolic Activity of the Human Faecal Flora. Microbial Ecology in Health and Disease, 1992. 5 (1): p. 43-50.
[11]
Riggio, O., et al., Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients. J Clin Gastroenterol, 1990. 12 (4): p. 433-6.
[12]
De Preter, V., et al., Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects. Aliment Pharmacol Ther, 2006. 23 (7): p. 963-74.
[13]
Kaur, A., et al., In vitro batch fecal fermentation comparison of gas and short-chain fatty acid production using "slowly fermentable" dietary fibers. J Food Sci, 2011. 76 (5): p. H137-42.
[14]
Van den Abbeele, P., et al., Arabinoxylo-Oligosaccharides and Inulin Impact Inter-Individual Variation on Microbial Metabolism and Composition, Which Immunomodulates Human Cells. J Agric Food Chem, 2018. 66 (5): p. 1121-1130.
[15]
Minekus, M., et al., A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Appl Microbiol Biotechnol, 1999. 53 (1): p. 108-14.
[16]
Molly, K., M. Vande Woestyne, and W. Verstraete, Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem. Appl Microbiol Biotechnol, 1993. 39 (2): p. 254-8.
[17]
Bothe, M. K., et al., Dose-Dependent Prebiotic Effect of Lactulose in a Computer-Controlled In Vitro Model of the Human Large Intestine. Nutrients, 2017. 9 (7).
[18]
Bothe, M., et al., Lactulose Crystals and Liquid Both Show A Dose-Dependent Prebiotic Effect in a Computer-Controlled In Vitro Model of the Human Proximal Colon. J Food Tech Food Chem 1: 103 Abstract RESEARCH ARTICLE Open Access, 2018. 1 (1).
[19]
Venema, K., et al., The Effect of Lactulose on the Composition of the Intestinal Microbiota and Short-chain Fatty Acid Production in Human Volunteers and a Computer-controlled Model of the Proximal Large Intestine. Microbial Ecology in Health and Disease, 2003. 15 (2-3): p. 94-105.
[20]
Aguirre, M., et al., In vitro characterization of the impact of different substrates on metabolite production, energy extraction and composition of gut microbiota from lean and obese subjects. PLoS One, 2014. 9 (11): p. e113864.
[21]
Eckburg, P. B., et al., Diversity of the human intestinal microbial flora. Science, 2005. 308 (5728): p. 1635-8.
[22]
Manach, C., et al., Addressing the inter‐individual variation in response to consumption of plant food bioactives: Towards a better understanding of their role in healthy aging and cardiometabolic risk reduction. Molecular Nutrition & Food Research, 2017. 61 (6): p. 1600557.
[23]
Van den Abbeele, P., et al., Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium cluster IX. Appl Environ Microbiol, 2010. 76 (15): p. 5237-46.
[24]
Van den Abbeele, P., et al., A combination of xylooligosaccharides and a polyphenol blend affect microbial composition and activity in the distal colon exerting immunomodulating properties on human cells. Journal of Functional Foods, 2018. 47: p. 163-171.
[25]
Van de Wiele, T., et al., The Simulator of the Human Intestinal Microbial Ecosystem (SHIME®), in The Impact of Food Bioactives on Health: in vitro and ex vivo models, K. Verhoeckx, et al., Editors. 2015, Springer International Publishing: Cham. p. 305-317.
[26]
Possemiers, S., et al., PCR-DGGE-based quantification of stability of the microbial community in a simulator of the human intestinal microbial ecosystem. FEMS Microbiol Ecol, 2004. 49 (3): p. 495-507.
[27]
De Weirdt, R., et al., Human faecal microbiota display variable patterns of glycerol metabolism. FEMS Microbiology Ecology, 2010. 74 (3): p. 601-611.
[28]
Van de Wiele, T., et al., Prebiotic effects of chicory inulin in the simulator of the human intestinal microbial ecosystem. FEMS Microbiol Ecol, 2004. 51 (1): p. 143-53.
[29]
Vilchez-Vargas, R., et al., Analysis of the microbial gene landscape and transcriptome for aromatic pollutants and alkane degradation using a novel internally calibrated microarray system. Environ Microbiol, 2013. 15 (4): p. 1016-39.
[30]
Collado, M. C., et al., Intestinal Integrity and Akkermansia muciniphila, a Mucin-Degrading Member of the Intestinal Microbiota Present in Infants, Adults, and the Elderly. Applied and Environmental Microbiology, 2007. 73 (23): p. 7767-7770.
[31]
Furet, J. P., et al., Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol, 2009. 68 (3): p. 351-62.
[32]
Rinttila, T., et al., Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol, 2004. 97 (6): p. 1166-77.
[33]
Klindworth, A., et al., Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res, 2013. 41 (1): p. e1.
[34]
Schloss, P. D. and S. L. Westcott, Assessing and improving methods used in operational taxonomic unit-based approaches for 16S rRNA gene sequence analysis. Appl Environ Microbiol, 2011. 77 (10): p. 3219-26.
[35]
Kozich, J. J., et al., Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol, 2013. 79 (17): p. 5112-20.
[36]
Wang, Q., et al., Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy. Applied and Environmental Microbiology, 2007. 73 (16): p. 5261-5267.
[37]
Van Herreweghen, F., et al., In vitro colonisation of the distal colon by Akkermansia muciniphila is largely mucin and pH dependent. Benef Microbes, 2017. 8 (1): p. 81-96.
[38]
Macfarlane, G. T. and G. R. Gibson, Carbohydrate fermentation, energy transduction and gas metabolism in the human large intestine, in Gastrointestinal Microbiology, R. I. Mackie, B. R. White, and R. E. Isaacson, Editors. 1996, Chapman and Hall: London, United Kingdom. p. 269-318.
[39]
Duncan, S. H., P. Louis, and H. J. Flint, Lactate-Utilizing Bacteria, Isolated from Human Feces, That Produce Butyrate as a Major Fermentation Product. Applied and Environmental Microbiology, 2004. 70 (10): p. 5810.
[40]
Raybaudi-Massilia, R. M., et al., Control of Pathogenic and Spoilage Microorganisms in Fresh-cut Fruits and Fruit Juices by Traditional and Alternative Natural Antimicrobials. Comprehensive Reviews in Food Science and Food Safety, 2009. 8 (3): p. 157-180.
[41]
Ballongue, J., C. Schumann, and P. Quignon, Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol Suppl, 1997. 222: p. 41-4.
[42]
Tuohy, K. M., et al., A Human Volunteer Study to Determine the Prebiotic Effects of Lactulose Powder on Human Colonic Microbiota. Microbial Ecology in Health and Disease, 2002. 14 (3): p. 165-173.
[43]
Vanhoutte, T., et al., Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii. Appl Environ Microbiol, 2006. 72 (9): p. 5990-7.
[44]
Hamer, H. M., et al., Review article: the role of butyrate on colonic function. Alimentary Pharmacology & Therapeutics, 2008. 27 (2): p. 104-119.
[45]
McNabney, S. M. and T. M. Henagan, Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer, Obesity and Insulin Resistance. Nutrients, 2017. 9 (12).
[46]
Flint, H., et al., Links between diet, gut microbiota composition and gut metabolism. Vol. 74. 2014. 1-10.
[47]
Sokol, H., et al., Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A, 2008. 105 (43): p. 16731-6.
[48]
Qiu, X., et al., Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. Journal of Crohn's and Colitis, 2013. 7 (11): p. e558-e568.
[49]
Cecchini, D. A., et al., Functional Metagenomics Reveals Novel Pathways of Prebiotic Breakdown by Human Gut Bacteria. PLoS ONE, 2013. 8 (9): p. e72766.
[50]
Rios-Covian, D., et al., Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiology Letters, 2015. 362 (21): p. fnv176-fnv176.
[51]
Hashizume, K., et al., Megasphaera elsdenii JCM1772T normalizes hyperlactate production in the large intestine of fructooligosaccharide-fed rats by stimulating butyrate production. J Nutr, 2003. 133 (10): p. 3187-90.
[52]
Schneeberger, M., et al., Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep, 2015. 5: p. 16643.
[53]
Van den Abbeele, P., et al., Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats. Environmental Microbiology, 2011. 13 (10): p. 2667-2680.
[54]
Mao, B., et al., Lactulose Differently Modulates the Composition of Luminal and Mucosal Microbiota in C57BL/6J Mice. Journal of Agricultural and Food Chemistry, 2016. 64 (31): p. 6240-6247.
Browse journals by subject